GlassScriptPhysician profile
Willard Keith Cupp
NPI 1265021406
$1,491.77
in general payments reported to CMS, 2019-2025
16 companies · $275 in 2025
The $275 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $302 · 2022: $385 · 2023: $366 · 2024: $164 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756 · Education: $48.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $755.76 |
| Education | $48.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $413.89 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $213.46 | 2022-2025 | Caplyta |
| Alkermes, INC. | $155.92 | 2022-2025 | Vivitrol, Aristada, Aristada Initio |
| Neurocrine Biosciences, INC. | $133.53 | 2021-2025 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $114.41 | 2021-2025 | Rexulti, Abilify Maintena |
| Lundbeck LLC | $86.35 | 2021-2022 | |
| Baxter Healthcare | $78.62 | 2022 | |
| Welch Allyn | $63.33 | 2021 | |
| Vanda Pharmaceuticals INC. | $61.89 | 2025 | Fanapt |
| Teva Pharmaceuticals USA, INC. | $54.80 | 2021-2022 | |
| Mylan Specialty L.P. | $20.18 | 2024 | Yupelri |
| Janssen Pharmaceuticals, INC | $20.01 | 2025 | Spravato |
| Gilead Sciences, INC. | $19.64 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.43 | 2021 | |
| Axsome Therapeutics, INC. | $19.03 | 2024 | Auvelity |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $17.28 | 2023 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Willard Cupp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.